Observational Study Of Donepezil In Routine Clinical Practice
NCT00843115 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 370
Last updated 2014-03-13
Summary
To characterize the comorbidities and medications of patients treated with donepezil in a routine clinical practice and to verify the therapeutic response of these patients.
Conditions
Interventions
- OTHER
-
donepezil
Routine clinical practice of prescribing donepezil as per the Canadian label. No drug was supplied as part of this study
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2008-04-30
- Completion
- 2008-04-30
More Related Trials
-
Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease
NCT00708552 ·Status: COMPLETED ·Phase: PHASE2
-
The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
NCT00571064 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease
NCT01082965 ·Status: TERMINATED ·Phase: NA
-
Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease
NCT00165737 ·Status: COMPLETED ·Phase: PHASE3
-
Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease
NCT02162251 ·Status: COMPLETED
-
Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease
NCT01539031 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease
NCT00188812 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).
NCT02695004 ·Status: COMPLETED ·Phase: PHASE1
-
Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-
NCT01129596 ·Status: COMPLETED
-
A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease
NCT00710684 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
NCT00930059 ·Status: COMPLETED ·Phase: PHASE2
-
Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia
NCT00174382 ·Status: TERMINATED ·Phase: PHASE3
-
A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease
NCT00988598 ·Status: COMPLETED ·Phase: PHASE1
-
Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
NCT00842816 ·Status: COMPLETED ·Phase: PHASE2
-
Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
NCT00408525 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)
NCT01466088 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease
NCT00948909 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of Donepezil Between the Naive Group and the Switching Group
NCT01023425 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease
NCT02097056 ·Status: COMPLETED ·Phase: PHASE4
-
Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease
NCT00501111 ·Status: COMPLETED ·Phase: PHASE2
-
Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
NCT00842673 ·Status: COMPLETED ·Phase: PHASE2
-
Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers
NCT00403520 ·Status: COMPLETED ·Phase: PHASE4
-
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease
NCT01251718 ·Status: COMPLETED
-
The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
NCT00381381 ·Status: COMPLETED ·Phase: PHASE4
-
Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)
NCT04730635 ·Status: COMPLETED ·Phase: PHASE1